Northern Trust’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Northern Trust’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-569,477	Closed	-$145K	–	4661
2023 Q1	$145K	Buy	569,477 +58,961	+12%	+$53.3K	﹤0.01%	3971
2022 Q4	$602K	Sell	510,516 -15,317	-3%	-$32.2K	﹤0.01%	3439
2022 Q3	$1.07M	Buy	525,833 +464,911	+763%	+$789K	﹤0.01%	3289
2022 Q2	$94K	Sell	60,922 -973	-2%	-$3.8K	﹤0.01%	4199
2022 Q1	$313K	Buy	+61,895	New	+$281K	﹤0.01%	3930

Northern Trust's PEAR Position: Q2 2023 in Review

Northern Trust sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 569,477 shares — an estimated $145K sold.

Northern Trust first reported a position in PEAR in Q1 2022 and held it in 5 quarters. The position peaked at $1.07M in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Northern Trust reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Northern Trust sold 569,477 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $145K.
Northern Trust first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Northern Trust's Pear Therapeutics, Inc. Class A Common Stock position peaked at $1.07M in Q3 2022.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.